256 related articles for article (PubMed ID: 667838)
1. Sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of the EMT6 tumor in vivo as determined by both tumor volume response and in vitro plating assay.
Twentyman PR
Cancer Res; 1978 Aug; 38(8):2395-400. PubMed ID: 667838
[TBL] [Abstract][Full Text] [Related]
2. Growth support of small B16 melanoma implants with nitrosourea-sterilized fractions of the same tumor.
Dykes DJ; Griswold DP; Schabel FM
Cancer Res; 1976 Jun; 36(6):2031-4. PubMed ID: 1268854
[TBL] [Abstract][Full Text] [Related]
3. Differential repair of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea-induced DNA damage in two human colon tumor cell lines.
Erickson LC; Osieka R; Kohn KW
Cancer Res; 1978 Mar; 38(3):802-8. PubMed ID: 626984
[TBL] [Abstract][Full Text] [Related]
4. Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea.
Sano Y; Hoshino T; Barker M; Deen DF
Cancer Res; 1984 Feb; 44(2):571-6. PubMed ID: 6692362
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of three nitrosourea derivatives on mammalian cell cycle progression.
Tobey RA; Crissman HA
Cancer Res; 1975 Feb; 35(2):460-70. PubMed ID: 1167349
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells.
Drewinko B; Loo TL; Gottlieb JA
Cancer Res; 1976 Feb; 36(2 Pt 1):511-5. PubMed ID: 1260749
[TBL] [Abstract][Full Text] [Related]
7. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Rosenblum ML; Wheeler KT; Wilson CB; Barker M; Knebel KD
Cancer Res; 1975 Jun; 35(6):1387-91. PubMed ID: 1131813
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.
Lohrmann HP; Lepp KA; Schreml W
J Natl Cancer Inst; 1982 Apr; 68(4):541-7. PubMed ID: 6951071
[TBL] [Abstract][Full Text] [Related]
10. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
11. Quantitative dose-response relations for the cytotoxic activity of chloroethylnitrosoureas in cell culture.
Weinkam RJ; Deen DF
Cancer Res; 1982 Mar; 42(3):1008-14. PubMed ID: 7059967
[TBL] [Abstract][Full Text] [Related]
12. Biological and biochemical effects of N-(2-chloroethyl)-N'-(trans-4-methylcyclohexyl)-N-nitrosourea on two transplantable murine colon tumors.
Wheeler GP; Bowdon BJ; Torbert JW; Webster J; Alexander JA
Cancer Res; 1983 Dec; 43(12 Pt 1):5837-45. PubMed ID: 6640534
[TBL] [Abstract][Full Text] [Related]
13. In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy.
Rosenblum ML; Knebel KD; Vasquez DA; Wilson CB
Cancer Res; 1976 Oct; 36(10):3718-25. PubMed ID: 953998
[TBL] [Abstract][Full Text] [Related]
14. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
[TBL] [Abstract][Full Text] [Related]
15. Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea, a predictor of therapeutic efficacy.
Brereton HD; Bryant TL; Young RC
Cancer Res; 1975 Sep; 35(9):2420-5. PubMed ID: 1149044
[TBL] [Abstract][Full Text] [Related]
16. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
[TBL] [Abstract][Full Text] [Related]
17. Microsomal metabolism of nitrosoureas.
Hill DL; Kirk MC; Struck RF
Cancer Res; 1975 Feb; 35(2):296-301. PubMed ID: 234031
[TBL] [Abstract][Full Text] [Related]
18. Preclinical studies and clinical correlation of the effect of alkylating dose.
Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
[TBL] [Abstract][Full Text] [Related]
19. Effect of anticancer chemotherapeutic agents on immune reactions of mice. I. Comparison of two nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea.
Ghaffar A; Lichter W; Wellham LL; Sigel MM
J Natl Cancer Inst; 1978 Jun; 60(6):1483-7. PubMed ID: 650710
[No Abstract] [Full Text] [Related]
20. Cellular replication kinetics and persistence of sister chromatid exchange-inducing lesions in normal and lymphoma AKR cells following exposure to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Biegel JA; Conner MK; Boggs SS
Cancer Res; 1982 Jul; 42(7):2816-20. PubMed ID: 7083172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
